Cargando…
Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model
BACKGROUND: Islet transplantation has progressively become a safe alternative to pancreas transplantation for the treatment of type 1 diabetes. However, the long-term results of islet transplantation could be significantly increased by improving the quality of the islet isolation technique even expl...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402566/ https://www.ncbi.nlm.nih.gov/pubmed/31074398 http://dx.doi.org/10.1186/s12893-018-0452-x |
_version_ | 1783566784911114240 |
---|---|
author | Veroux, Massimiliano Bottino, Rita Santini, Roberta Bertera, Suzanne Corona, Daniela Zerbo, Domenico Li Volti, Giovanni Ekser, Burcin Puzzo, Lidia Raffaele, Marco Lo Bianco, Salvatore Giaquinta, Alessia Veroux, Pierfrancesco Vanella, Luca |
author_facet | Veroux, Massimiliano Bottino, Rita Santini, Roberta Bertera, Suzanne Corona, Daniela Zerbo, Domenico Li Volti, Giovanni Ekser, Burcin Puzzo, Lidia Raffaele, Marco Lo Bianco, Salvatore Giaquinta, Alessia Veroux, Pierfrancesco Vanella, Luca |
author_sort | Veroux, Massimiliano |
collection | PubMed |
description | BACKGROUND: Islet transplantation has progressively become a safe alternative to pancreas transplantation for the treatment of type 1 diabetes. However, the long-term results of islet transplantation could be significantly increased by improving the quality of the islet isolation technique even exploring alternative islet transplantation sites to reduce the number of islets required to mitigate hyperglycemia. The goal of the study was to test the lymph node as a suitable anatomical location for islet engraftment in a rodent model. METHODS: Forty Lewis rats, 6–8 weeks old, body weight 250–300 g, have been used as islet donors and recipients in syngeneic islet transplantation experiments. Ten rats were rendered diabetic by one injection of 65 mg/Kg of streptozotocin. After pancreas retrieval from non diabetic donors, islet were isolated and transplanted in the mesenteric lymph nodes of 7 diabetic rats. Rats were followed for 30 days after islet transplantation. RESULTS: A total of 7 islet transplantations in mesenteric lymph nodes have been performed. Two rats died 24 and 36 h after transplantation due to complications. No transplanted rat acquired normal glucose blood levels and insulin independence after the transplantation. However, the mean blood levels of glycemia were significantly lower in transplanted rats compared with diabetic rats (470.4 mg/dl vs 605 mg/dl, p 0.04). Interestingly, transplanted rats have a significant weight increase after transplantation compared to diabetic rats (mean value 295 g in transplanted rats vs 245 g in diabetic rats, p < 0.05), with an overall improvement of social activities and health. Immunohistochemical analysis of the 5 mesenteric lymph nodes of transplanted rats demonstrated the presence of living islets in one lymph node. CONCLUSIONS: Although islet engraftment in lymph nodes is possible, islet transplantation in lymph nodes in rats resulted in few improvements of glucose parameters. |
format | Online Article Text |
id | pubmed-7402566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-74025662020-08-07 Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model Veroux, Massimiliano Bottino, Rita Santini, Roberta Bertera, Suzanne Corona, Daniela Zerbo, Domenico Li Volti, Giovanni Ekser, Burcin Puzzo, Lidia Raffaele, Marco Lo Bianco, Salvatore Giaquinta, Alessia Veroux, Pierfrancesco Vanella, Luca BMC Surg Research Article BACKGROUND: Islet transplantation has progressively become a safe alternative to pancreas transplantation for the treatment of type 1 diabetes. However, the long-term results of islet transplantation could be significantly increased by improving the quality of the islet isolation technique even exploring alternative islet transplantation sites to reduce the number of islets required to mitigate hyperglycemia. The goal of the study was to test the lymph node as a suitable anatomical location for islet engraftment in a rodent model. METHODS: Forty Lewis rats, 6–8 weeks old, body weight 250–300 g, have been used as islet donors and recipients in syngeneic islet transplantation experiments. Ten rats were rendered diabetic by one injection of 65 mg/Kg of streptozotocin. After pancreas retrieval from non diabetic donors, islet were isolated and transplanted in the mesenteric lymph nodes of 7 diabetic rats. Rats were followed for 30 days after islet transplantation. RESULTS: A total of 7 islet transplantations in mesenteric lymph nodes have been performed. Two rats died 24 and 36 h after transplantation due to complications. No transplanted rat acquired normal glucose blood levels and insulin independence after the transplantation. However, the mean blood levels of glycemia were significantly lower in transplanted rats compared with diabetic rats (470.4 mg/dl vs 605 mg/dl, p 0.04). Interestingly, transplanted rats have a significant weight increase after transplantation compared to diabetic rats (mean value 295 g in transplanted rats vs 245 g in diabetic rats, p < 0.05), with an overall improvement of social activities and health. Immunohistochemical analysis of the 5 mesenteric lymph nodes of transplanted rats demonstrated the presence of living islets in one lymph node. CONCLUSIONS: Although islet engraftment in lymph nodes is possible, islet transplantation in lymph nodes in rats resulted in few improvements of glucose parameters. BioMed Central 2019-04-24 /pmc/articles/PMC7402566/ /pubmed/31074398 http://dx.doi.org/10.1186/s12893-018-0452-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Veroux, Massimiliano Bottino, Rita Santini, Roberta Bertera, Suzanne Corona, Daniela Zerbo, Domenico Li Volti, Giovanni Ekser, Burcin Puzzo, Lidia Raffaele, Marco Lo Bianco, Salvatore Giaquinta, Alessia Veroux, Pierfrancesco Vanella, Luca Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model |
title | Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model |
title_full | Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model |
title_fullStr | Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model |
title_full_unstemmed | Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model |
title_short | Mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model |
title_sort | mesenteric lymph nodes as alternative site for pancreatic islet transplantation in a diabetic rat model |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402566/ https://www.ncbi.nlm.nih.gov/pubmed/31074398 http://dx.doi.org/10.1186/s12893-018-0452-x |
work_keys_str_mv | AT verouxmassimiliano mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT bottinorita mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT santiniroberta mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT berterasuzanne mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT coronadaniela mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT zerbodomenico mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT livoltigiovanni mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT ekserburcin mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT puzzolidia mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT raffaelemarco mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT lobiancosalvatore mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT giaquintaalessia mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT verouxpierfrancesco mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel AT vanellaluca mesentericlymphnodesasalternativesiteforpancreaticislettransplantationinadiabeticratmodel |